RASSF10 and neoplasm: Since we observed in the Rassf1A−/− and TP53−/− mice background increased neoplasia for the Rassf10 knockout (Table 2), we analyzed overall survival rate in 288 renal papillary carcinomas with the low RASSF10 and RASSF1 or TP53 expression in renal papillary cell carcinoma [42] (Supplementary Fig. S6).